BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 59 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,003,610 | -20.8% | 25,635 | -17.8% | 0.01% | -23.1% |
| Q2 2023 | $1,266,993 | +23.8% | 31,176 | +27.5% | 0.01% | +18.2% |
| Q1 2023 | $1,023,472 | +0.4% | 24,450 | +4.5% | 0.01% | +22.2% |
| Q4 2022 | $1,019,423 | -99.9% | 23,392 | -51.3% | 0.01% | -10.0% |
| Q3 2022 | $931,931,000 | +94608.4% | 47,984 | +106.8% | 0.01% | 0.0% |
| Q2 2022 | $984,000 | -8.2% | 23,204 | -1.5% | 0.01% | -9.1% |
| Q1 2022 | $1,072,000 | +1.9% | 23,546 | +8.6% | 0.01% | 0.0% |
| Q4 2021 | $1,052,000 | +6.3% | 21,684 | +4.3% | 0.01% | +10.0% |
| Q3 2021 | $990,000 | -4.3% | 20,787 | -2.5% | 0.01% | -16.7% |
| Q2 2021 | $1,034,000 | +14.6% | 21,310 | +9.3% | 0.01% | +9.1% |
| Q1 2021 | $902,000 | -22.5% | 19,499 | -19.5% | 0.01% | -15.4% |
| Q4 2020 | $1,164,000 | -99.8% | 24,228 | +39.5% | 0.01% | -7.1% |
| Q3 2020 | $744,000,000 | – | 17,368 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RENAISSANCE INVESTMENT CONSULTANTS HOLDING COMPANY, LLC | 18,736 | $675,000 | 0.94% |
| CORRADO ADVISORS, LLC | 9,565 | $344,000 | 0.32% |
| Rikoon Group, LLC | 19,188 | $692,000 | 0.29% |
| Eudaimonia Partners, LLC | 4,875 | $176,000 | 0.08% |
| Arete Wealth Advisors, LLC | 10,183 | $367,000 | 0.07% |
| CENTAURUS FINANCIAL, INC. | 8,465 | $305,000 | 0.06% |
| Cetera Advisors LLC | 17,379 | $627,000 | 0.03% |
| Jacobi Capital Management LLC | 4,034 | $145,000 | 0.03% |
| Financial Advantage, Inc. | 773 | $27,000 | 0.02% |
| MID ATLANTIC FINANCIAL MANAGEMENT INC/ADV | 5,868 | $212,000 | 0.02% |